首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Regulatory Sequences of the Porcine THBD Gene Facilitate Endothelial-Specific Expression of Bioactive Human Thrombomodulin in Single- and Multitransgenic Pigs
【24h】

Regulatory Sequences of the Porcine THBD Gene Facilitate Endothelial-Specific Expression of Bioactive Human Thrombomodulin in Single- and Multitransgenic Pigs

机译:猪THBD基因的调控序列促进单转基因和多转基因猪中生物活​​性人血栓调节蛋白的内皮特异性表达。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Among other mismatches between human and pig, incompatibilities in the blood coagulation systems hamper the xenotransplantation of vascularized organs. The provision of the porcine endothelium with human thrombomodulin (hTM) is hypothesized to overcome the impaired activation of protein C by a heterodimer consisting of human thrombin and porcine TM. METHODS: We evaluated regulatory regions of the THBD gene, optimized vectors for transgene expression, and generated hTM expressing pigs by somatic cell nuclear transfer. Genetically modified pigs were characterized at the molecular, cellular, histological, and physiological levels. RESULTS: A 7.6-kb fragment containing the entire upstream region of the porcine THBD gene was found to drive a high expression in a porcine endothelial cell line and was therefore used to control hTM expression in transgenic pigs. The abundance of hTM was restricted to the endothelium, according to the predicted pattern, and the transgene expression of hTM was stably inherited to the offspring. When endothelial cells from pigs carrying the hTM transgene - either alone or in combination with an aGalTKO and a transgene encoding the human CD46 - were tested in a coagulation assay with human whole blood, the clotting time was increased three- to four-fold (P<0.001) compared to wild-type and aGalTKO/CD46 transgenic endothelial cells. This, for the first time, demonstrated the anticoagulant properties of hTM on porcine endothelial cells in a human whole blood assay. CONCLUSIONS: The biological efficacy of hTM suggests that the (multi-)transgenic donor pigs described here have the potential to overcome coagulation incompatibilities in pig-to-primate xenotransplantation.
机译:背景:除人与猪之间的其他不匹配之外,血液凝固系统的不相容性阻碍了血管化器官的异种移植。假设提供具有人血栓调节蛋白(hTM)的猪内皮可以克服由人凝血酶和猪TM组成的异二聚体对蛋白C活化的损害。方法:我们评估了THBD基因的调控区,优化了转基因表达的载体,并通过体细胞核移植产生了表达hTM的猪。转基因猪的特征在于分子,细胞,组织学和生理学水平。结果发现,包含猪THBD基因整个上游区域的7.6kb片段可在猪内皮细胞系中驱动高表达,因此可用于控制hTM在转基因猪中的表达。根据预测的模式,hTM的丰度仅限于内皮细胞,hTM的转基因表达稳定地遗传给后代。在携带人全血的凝血试验中检测携带hTM转基因的猪的内皮细胞-单独或与aGalTKO和编码人CD46的转基因组合使用时,凝血时间增加了三倍至四倍(P与野生型和aGalTKO / CD46转基因内皮细胞相比,<0.001)。这首次证明了hTM在人全血测定中对猪内皮细胞的抗凝特性。结论:hTM的生物学功效表明,本文所述的(多)转基因供体猪具有克服猪到灵长类动物异种移植过程中凝血不相容的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号